Exergaming in People With Major Neurocognitive Disorder
NCT ID: NCT04436302
Last Updated: 2020-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2019-01-02
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Individualized Exergame Training Solution for People With Major Neurocognitive Disorder: a Usability Study
NCT04664920
Intervention Study of an Individualized Exergame Training for People With Major Neurocognitive Disorder
NCT04436315
Exergaming Revolution in Dementia
NCT06631742
Effectiveness of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder
NCT05387057
Concurrent Aerobic Exercise and Virtual Reality Cognitive Training
NCT02963415
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Dividat senso exergame device
Exergame device
motor-cognitive training
Control
Listening to music
Exergame device
motor-cognitive training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exergame device
motor-cognitive training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 65 years or older
* a score of minimum 10 on the Mini-Mental State Examination (MMSE)
* residing at least two weeks in the care facility at the time of inclusion
* being physically capable of doing standing exercises (whether or not with extra support).
Possible causes of MNCD were vascular dementia, Alzheimer's disease, mixed dementia, Parkinson's disease or Lewy body disease.
Exclusion Criteria
* a score lower than 10 on the MMSE
* a planned transfer to another setting within the following two months.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Davy Vancampfort
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Davy Vancampfort
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Long-term care facility 'de Wingerd'
Leuven, Vlaams Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Riekje Akkerman
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Swinnen N, Vandenbulcke M, de Bruin ED, Akkerman R, Stubbs B, Firth J, Vancampfort D. The efficacy of exergaming in people with major neurocognitive disorder residing in long-term care facilities: a pilot randomized controlled trial. Alzheimers Res Ther. 2021 Mar 30;13(1):70. doi: 10.1186/s13195-021-00806-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
042020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.